The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Transdermal Skin Patches-Global Market Insights and Sales Trends 2024
Synopsis
The global Transdermal Skin Patches market size is expected to reach US$ 52 million by 2029, growing at a CAGR of 2.7% from 2023 to 2029. The market is mainly driven by the significant applications of Transdermal Skin Patches in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Transdermal Skin Patches market. Drug in Adhesive, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Matrix segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Transdermal Skin Patches market, driven by demand from China, the second largest economy with some signs of stabilising, the Transdermal Skin Patches market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transdermal Skin Patches, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transdermal Skin Patches market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transdermal Skin Patches market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transdermal Skin Patches sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transdermal Skin Patches covered in this report include Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Luye Pharma Group, Hisamitsu Pharmaceutical, Mundipharma International and Purdue Pharma, etc.
The global Transdermal Skin Patches market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Luye Pharma Group
Hisamitsu Pharmaceutical
Mundipharma International
Purdue Pharma
Global Transdermal Skin Patches market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transdermal Skin Patches market, Segment by Type:
Drug in Adhesive
Matrix
Reservoir
Vapor
Others
Global Transdermal Skin Patches market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Transdermal Skin Patches manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Transdermal Skin Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Transdermal Skin Patches market size is expected to reach US$ 52 million by 2029, growing at a CAGR of 2.7% from 2023 to 2029. The market is mainly driven by the significant applications of Transdermal Skin Patches in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Transdermal Skin Patches market. Drug in Adhesive, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Matrix segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Transdermal Skin Patches market, driven by demand from China, the second largest economy with some signs of stabilising, the Transdermal Skin Patches market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transdermal Skin Patches, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transdermal Skin Patches market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transdermal Skin Patches market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transdermal Skin Patches sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transdermal Skin Patches covered in this report include Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Luye Pharma Group, Hisamitsu Pharmaceutical, Mundipharma International and Purdue Pharma, etc.
The global Transdermal Skin Patches market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Luye Pharma Group
Hisamitsu Pharmaceutical
Mundipharma International
Purdue Pharma
Global Transdermal Skin Patches market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transdermal Skin Patches market, Segment by Type:
Drug in Adhesive
Matrix
Reservoir
Vapor
Others
Global Transdermal Skin Patches market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Transdermal Skin Patches manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Transdermal Skin Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Transdermal Skin Patches Market Overview
1.1 Transdermal Skin Patches Product Overview
1.2 Transdermal Skin Patches Market Segment by Type
1.2.1 Drug in Adhesive
1.2.2 Matrix
1.2.3 Reservoir
1.2.4 Vapor
1.2.5 Others
1.3 Global Transdermal Skin Patches Market Size by Type
1.3.1 Global Transdermal Skin Patches Market Size Overview by Type (2018-2029)
1.3.2 Global Transdermal Skin Patches Historic Market Size Review by Type (2018-2023)
1.3.3 Global Transdermal Skin Patches Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Transdermal Skin Patches Sales Breakdown by Type (2018-2023)
1.4.2 Europe Transdermal Skin Patches Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Transdermal Skin Patches Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Transdermal Skin Patches Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Transdermal Skin Patches Sales Breakdown by Type (2018-2023)
2 Global Transdermal Skin Patches Market Competition by Company
2.1 Global Top Players by Transdermal Skin Patches Sales (2018-2023)
2.2 Global Top Players by Transdermal Skin Patches Revenue (2018-2023)
2.3 Global Top Players by Transdermal Skin Patches Price (2018-2023)
2.4 Global Top Manufacturers Transdermal Skin Patches Manufacturing Base Distribution, Sales Area, Product Type
2.5 Transdermal Skin Patches Market Competitive Situation and Trends
2.5.1 Transdermal Skin Patches Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Transdermal Skin Patches Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Skin Patches as of 2022)
2.7 Date of Key Manufacturers Enter into Transdermal Skin Patches Market
2.8 Key Manufacturers Transdermal Skin Patches Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Transdermal Skin Patches Status and Outlook by Region
3.1 Global Transdermal Skin Patches Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Transdermal Skin Patches Historic Market Size by Region
3.2.1 Global Transdermal Skin Patches Sales in Volume by Region (2018-2023)
3.2.2 Global Transdermal Skin Patches Sales in Value by Region (2018-2023)
3.2.3 Global Transdermal Skin Patches Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Transdermal Skin Patches Forecasted Market Size by Region
3.3.1 Global Transdermal Skin Patches Sales in Volume by Region (2024-2029)
3.3.2 Global Transdermal Skin Patches Sales in Value by Region (2024-2029)
3.3.3 Global Transdermal Skin Patches Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Transdermal Skin Patches by Application
4.1 Transdermal Skin Patches Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Transdermal Skin Patches Market Size by Application
4.2.1 Global Transdermal Skin Patches Market Size Overview by Application (2018-2029)
4.2.2 Global Transdermal Skin Patches Historic Market Size Review by Application (2018-2023)
4.2.3 Global Transdermal Skin Patches Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Transdermal Skin Patches Sales Breakdown by Application (2018-2023)
4.3.2 Europe Transdermal Skin Patches Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Transdermal Skin Patches Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Transdermal Skin Patches Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Transdermal Skin Patches Sales Breakdown by Application (2018-2023)
5 North America Transdermal Skin Patches by Country
5.1 North America Transdermal Skin Patches Historic Market Size by Country
5.1.1 North America Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Transdermal Skin Patches Sales in Volume by Country (2018-2023)
5.1.3 North America Transdermal Skin Patches Sales in Value by Country (2018-2023)
5.2 North America Transdermal Skin Patches Forecasted Market Size by Country
5.2.1 North America Transdermal Skin Patches Sales in Volume by Country (2024-2029)
5.2.2 North America Transdermal Skin Patches Sales in Value by Country (2024-2029)
6 Europe Transdermal Skin Patches by Country
6.1 Europe Transdermal Skin Patches Historic Market Size by Country
6.1.1 Europe Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Transdermal Skin Patches Sales in Volume by Country (2018-2023)
6.1.3 Europe Transdermal Skin Patches Sales in Value by Country (2018-2023)
6.2 Europe Transdermal Skin Patches Forecasted Market Size by Country
6.2.1 Europe Transdermal Skin Patches Sales in Volume by Country (2024-2029)
6.2.2 Europe Transdermal Skin Patches Sales in Value by Country (2024-2029)
7 Asia-Pacific Transdermal Skin Patches by Region
7.1 Asia-Pacific Transdermal Skin Patches Historic Market Size by Region
7.1.1 Asia-Pacific Transdermal Skin Patches Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Transdermal Skin Patches Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Transdermal Skin Patches Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Transdermal Skin Patches Forecasted Market Size by Region
7.2.1 Asia-Pacific Transdermal Skin Patches Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Transdermal Skin Patches Sales in Value by Region (2024-2029)
8 Latin America Transdermal Skin Patches by Country
8.1 Latin America Transdermal Skin Patches Historic Market Size by Country
8.1.1 Latin America Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Transdermal Skin Patches Sales in Volume by Country (2018-2023)
8.1.3 Latin America Transdermal Skin Patches Sales in Value by Country (2018-2023)
8.2 Latin America Transdermal Skin Patches Forecasted Market Size by Country
8.2.1 Latin America Transdermal Skin Patches Sales in Volume by Country (2024-2029)
8.2.2 Latin America Transdermal Skin Patches Sales in Value by Country (2024-2029)
9 Middle East and Africa Transdermal Skin Patches by Country
9.1 Middle East and Africa Transdermal Skin Patches Historic Market Size by Country
9.1.1 Middle East and Africa Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Transdermal Skin Patches Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Transdermal Skin Patches Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Transdermal Skin Patches Forecasted Market Size by Country
9.2.1 Middle East and Africa Transdermal Skin Patches Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Transdermal Skin Patches Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Transdermal Skin Patches Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Johnson & Johnson Transdermal Skin Patches Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Company Information
10.2.2 Novartis AG Introduction and Business Overview
10.2.3 Novartis AG Transdermal Skin Patches Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis AG Transdermal Skin Patches Products Offered
10.2.5 Novartis AG Recent Development
10.3 Mylan N.V.
10.3.1 Mylan N.V. Company Information
10.3.2 Mylan N.V. Introduction and Business Overview
10.3.3 Mylan N.V. Transdermal Skin Patches Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mylan N.V. Transdermal Skin Patches Products Offered
10.3.5 Mylan N.V. Recent Development
10.4 Teva Pharmaceutical Industries
10.4.1 Teva Pharmaceutical Industries Company Information
10.4.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.4.3 Teva Pharmaceutical Industries Transdermal Skin Patches Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva Pharmaceutical Industries Transdermal Skin Patches Products Offered
10.4.5 Teva Pharmaceutical Industries Recent Development
10.5 Luye Pharma Group
10.5.1 Luye Pharma Group Company Information
10.5.2 Luye Pharma Group Introduction and Business Overview
10.5.3 Luye Pharma Group Transdermal Skin Patches Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Luye Pharma Group Transdermal Skin Patches Products Offered
10.5.5 Luye Pharma Group Recent Development
10.6 Hisamitsu Pharmaceutical
10.6.1 Hisamitsu Pharmaceutical Company Information
10.6.2 Hisamitsu Pharmaceutical Introduction and Business Overview
10.6.3 Hisamitsu Pharmaceutical Transdermal Skin Patches Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Hisamitsu Pharmaceutical Transdermal Skin Patches Products Offered
10.6.5 Hisamitsu Pharmaceutical Recent Development
10.7 Mundipharma International
10.7.1 Mundipharma International Company Information
10.7.2 Mundipharma International Introduction and Business Overview
10.7.3 Mundipharma International Transdermal Skin Patches Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Mundipharma International Transdermal Skin Patches Products Offered
10.7.5 Mundipharma International Recent Development
10.8 Purdue Pharma
10.8.1 Purdue Pharma Company Information
10.8.2 Purdue Pharma Introduction and Business Overview
10.8.3 Purdue Pharma Transdermal Skin Patches Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Purdue Pharma Transdermal Skin Patches Products Offered
10.8.5 Purdue Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Transdermal Skin Patches Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Transdermal Skin Patches Industrial Chain Analysis
11.4 Transdermal Skin Patches Market Dynamics
11.4.1 Transdermal Skin Patches Industry Trends
11.4.2 Transdermal Skin Patches Market Drivers
11.4.3 Transdermal Skin Patches Market Challenges
11.4.4 Transdermal Skin Patches Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Transdermal Skin Patches Distributors
12.3 Transdermal Skin Patches Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
